Amgen | AMGN - Przychody Ze Sprzedaży





Obroty Zmiana Data
AbbVie USD 15B 1.62B 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
ALKERMES USD 392.91M 8.41M 2026-03
Amgen USD 8.62B 1.28B 2026-03
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eli Lilly USD 19.8B 500M 2026-03
Exelixis USD 610.8M 12.14M 2026-03
Genmab DKK 1.06B 36M 2025-12
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Incyte USD 1.27B 240M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
J&J USD 24.1B 500M 2026-03
Merck USD 16.29B 110M 2026-03
Moderna USD 389M 289M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
Novartis USD 13.11B 226M 2026-03
Novartis USD 13.11B 750M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Takeda JPY 1.09T 100B 2026-03
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03